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Paraneoplastic pemphigus is an autoimmune
disease associated with an underlying tumor.
Several cases have been reported as unusual
pemphigus vulgaris, erythema multiforme, or
paraneoplastic bullous disease,1 but the incidence
of the condition is unknown.2 Response to treatment
is generally poor, with significant morbidity and
mortality.
This condition is clinically characterized by
severe mucositis and polymorphic blistering skin
eruptions, and histologically by acantholysis,
keratinocyte necrosis, and interface dermatitis.3
Immunoprecipitation and immunoblot testing detect
autoantibodies against desmosomal polypeptides.4
We describe a case of paraneoplastic pemphigus
associated with an abdominal inflammatory myofi-
broblastic tumor in a 7-year-old girl.Fig 1. A, Back. B, Lips.CASE REPORT
A previously healthy 7-year-old girl from the city
of Valledupar, Colombia, presented to a different
Institution in March 2009, with a 2-month history of
severe depression, oral ulcers, denuded lips, and
progressive bullae involving the face, extremities,
and lower back and affecting 40% of her body
surface (Figs 1 and 2). She had pemphigus vulgaris
diagnosed by skin biopsy (Fig 3) and direct
immunofluorescence and received treatment with
oral prednisone, thalidomide, and azathioprine, with
minimal improvement.
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Fig 2. A, Finger. B, Soles.
Fig 3. Skin biopsy taken before treatment initiation shows
acantholytic intraepidermal vesicular dermatitis suggestive
of vulgaris pemphigus.
Fig 4. Abdominal ultrasound scan shows a 55-mm,
hypoechoic, solid mass with low resistance.
Fig 5. Biopsy of the abdominal mass found a fusocellular
lesion associated with a mononuclear inflammatory
infiltrate. A histologic diagnosis of an inflammatory
myofibroblastic tumor was made.
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disease, psychiatry, and endocrinology. Initial
management included intravenous immunoglob-
ulin, methylprednisolone, azathioprine, oxacillin,
rituximab (4 doses), and psychotherapy. After40 days of hospitalization, skin lesions partially
improved. After discharge, prolonged courses of
prednisone and continuous azathioprine tempo-
rarily controlled her disease. Cushing’s syndrome,
a small cataract, skin infections, and myopathy
developed as side effects of therapy.
Between April 2010 and July 2011, she required
multiple hospitalizations for relapses and skin
infections. In August 2011, she was seen in the
emergency room for severe abdominal pain and
fever. Salmonellosis was documented, and an
abdominal ultrasound scan found a 55-mm
vascularized mass in the right flank (Fig 4); biopsy
of the mass showed an inflammatory myofibroblastic
tumor (Fig 5).
Table I. Original diagnostic criteria for paraneoplastic pemphigus (Anhalt et al1)
1. Painful mucosal ulcerations and blisters and a polymorphous skin eruption in the context of an occult or known
neoplasm
2. Intraepidermal acantholysis, keratinocyte necrosis, and vacuolar interface changes in histopathology
3. Deposition of IgG and complement C3 in intercellular epidermal and basement membrane zones seen on direct
immunofluorescence
4. Detection of serum autoantibodies to stratified squamous epithelia, columnar, and transitional epithelia by indirect
immunofluorescence
5. Serum immunoprecipitation of a characteristic complex of four proteins (250, 230, 210, and 190 kDa) from keratinocytes
of transitional epithelia by indirect immunofluorescence
Table II. Camisa and Helm criteria for the diagnosis of paraneoplastic pemphigus11
Major Criteria
1. Polymorphous mucocutaneous eruption
2. Concurrent internal neoplasia
3. Characteristic serum immunoprecipitation findings
Minor Criteria
1. Positive cytoplasmic staining of rat bladder by immunofluorescence
2. Intercellular and basement membrane zone immunoreactants on direct immunofluorescence of perilesional tissue
3. Acantholysis in biopsy specimen from at least one anatomic site of involvement
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possible, with the remaining 5% adhered to the
internal iliac vein. After surgery, the skin lesions
began to improve and disappeared. At 4 years of
follow-up, the residual tumor remains stable, and
she remains asymptomatic without medications.
DISCUSSION
Paraneoplastic pemphigus is a neoplasia-
associated autoimmune disease, first described by
Anhalt et al,5 characterized by the production
of autoantibodies against a complex of desmo-
somal proteins (desmoplakin I and II, bullous
pemphigoid antigen 1, envoplakin, periplakin
and desmoglein).6,7
Paraneoplastic pemphigus is mainly associated
with lymphoproliferative disorders such as non-
Hodgkin lymphoma, chronic lymphocytic leukemia,
and Castleman’s disease. Nonlymphoid malignant
neoplasms, such as benign thymomas,8,9 poorly
differentiated sarcomas, and carcinomas of the
lung, colon, pancreas,10 and cervix11 are rarely
associated.12,13
Stomatitis is a cardinal feature and often the
earliest presenting sign and is extremely resistant to
therapy. Patients can present with vesicles, bullae,
erosions, crusting, pruritic skin eruption resembling
bullous pemphigoid,14 and erythematous papules
with central vesiculation resembling erythemamultiforme. Nikolsky sign can occasionally be
seen.15 Blisters and lichenoid lesions on the palms
and soles, and pseudomembranous conjunctivitis, as
in our patient’s case, help to differentiate the condi-
tion from pemphigus vulgaris.16 The most
commonly affected areas are the trunk, proximal
extremities, head, and neck.17
In 1990, Anhalt et al5 proposed diagnostic criteria
(Table I), which Camisa andHelm18modified in 1993
(Table II).
The course of Paraneoplastic pemphigus does
not necessarily parallel the course of the underlying
neoplasm. This condition can be associated
with pulmonary disease including bronchiolitis
obliterans and IgG deposits in respiratory
epithelium, which in some cases may lead to
respiratory failure accounting for the mortality cause
in these patients.19,20
Inflammatory myofibroblastic tumors are rare
neoplastic lesions that occur primarily in children
and young adults.21 They may present in any organ,
most often seen in soft tissues, lungs, and
abdomen.22 These tumors were considered to
have a benign clinical course, but now it is
recognized that they can have an aggressive
behavior and occasionally an unfavorable
prognosis.23 Few cases of paraneoplastic pemphigus
associated with inflammatory myofibroblastic
tumors have been reported,24 none in children.
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metastasizes. In most cases, complete surgical
resection of the lesion is curative.
Although paraneoplastic pemphigus is rare in
childhood and adolescence, it should be included
in the differential diagnosis of periorificial erosive
dermatitis. Lesions that are refractory to therapy
should prompt an aggressive search for a possible
occult neoplasm with imaging of the chest,
abdomen, and pelvis.REFERENCES
1. Anhalt GJ. Paraneoplastic pemphigus. Adv Dermatol. 1997;12:
77-96.
2. Cervini AB, Tosi V, Kim SH, et al. Case Report: Paraneoplastic
Pemphigus or Paraneoplastic Autoimmune Multiorgan
Syndrome. Report of 2 Cases in Children and a Review of
the Literature. Actas Dermosifiliogr. 2010;101(10):879-886.
3. Mahajan VK, Sharma V, Chauhan PS, et al. Paraneoplastic
Pemphigus: A Paraneoplastic Autoimmune Multiorgan Syn-
drome or Autoimmune Multiorganopathy? Case Rep Dermatol
Med. 2012;2012:207126.
4. Sehgal VN, Srivastava G. ‘‘Paraneoplastic pemphigus/
paraneoplastic autoimmune multiorgan syndrome’’. Int J
Dermatol. 2009;48(2):162-169.
5. Anhalt GJ, Kim SC, Standley JR, et al. Paraneoplastic
pemphigus. An autoimmune mucocutaneous disease
associated with neoplasia. N Engl J Med. 1990;323:1729-1735.
6. Ohyama M, Amagai M, Hashimoto T, Nousari HC, Anhalt GJ,
Nishikawa T. Clinical phenotype and anti-desmoglein
autoantibody profile in paraneoplastic pemphigus. J Am
Acad Dermatol. 2001;44(4):593-598.
7. Schepens I, Jaunin F, Begre N, et al. The protease inhibitor
alpha-2-macroglobulinelike-1 is the p170 antigen recognized
by paraneoplastic pemphigus autoantibodies in human. PLoS
One. 2010;5(8):e12250.
8. Hartz RS, Daroca PJ. Clinical-pathological conference: cutaneous
paraneoplastic pemphigus associatedwith benign encapsulated
thymoma. J Thorac Cardiovasc Surg. 2003;125:400-406.
9. Leyn J, Degreef H. Paraneoplastic pemphigus in a patient with
a thymoma. Dermatology. 2001;202:151-154.
10. Matz H, Milner Y, Frusic-Zlotkin M, Brenner S. Paraneoplastic
pemphigus associated with pancreatic carcinoma. Acta Derm
Venereol (Stockh). 1997;77:289-291.11. Chorzelski T, Hashimoto T, Maciejewska B, Amagai M,
Anhalt GJ, Jablonska S. Paraneoplastic pemphigus associated
with Castleman tumor, myasthenia gravis, and bronchiolitis
obliterans. J Am Acad Dermatol. 1999;41:393-400.
12. Lemon MA, Weston WL, Huff JC. Childhood paraneoplastic
pemphigus associated with Castleman’s tumour. Br J
Dermatol. 1997;136(1):115-117.
13. Rodot S, Botcazou V, Lacour JP, et al. Paraneoplastic
pemphigus: review of the literature, apropos of a case
associated with chronic lymphoid leukemia. Rev Med Interne.
1995;16(12):938-943.
14. Coelho S, Reis JP, Tellechea O, Figueiredo A, Black M.
Paraneoplastic pemphigus with clinical features of lichen
planus associated with low-grade B cell lymphoma. Int J
Dermatol. 2005;44(5):366-371.
15. Jansen T, Plewig G, Anhalt GJ. Paraneoplastic pemphigus with
clinical features of erosive lichen planus associated with
Castelman’s tumor. Dermatology. 1995;190:245-250.
16. Allen CM, Camisa C. Paraneoplastic pemphigus: a review of
the literature. Oral Dis. 2000;6:208-214.
17. Robinson ND, Hashimoto T, Amagai M, et al. The
new pemphigus variants. J Am Acad Dermatol. 1999;40:
649-671.
18. Camisa C, Helm TN. Paraneoplastic pemphigus is a distinct
neoplasia-induced autoimmune disease. Arch Dermatol. 1993;
129:883-885.
19. Lane JE, Woody C, Davis LS, Guill MF, Jerath RS. Paraneoplastic
autoimmune multiorgan syndrome (paraneoplastic pemphigus)
in a child: case report and reviewof the literature. Pediatrics. 2004;
114(4):e513-e516.
20. Takahashi M, Shimatsu Y, Kazama T, Kimura K, Otsuka T,
Hashimoto T. paraneoplastic pemphigus associated with
bronchiolitis obliterans. Chest. 2000;117:603-607.
21. Coffin CM, Watterson J, Pries JR, et al. Extrapulmonary inflam-
matory myofibroblastic tumor (inflammatory pseudotumor).
A clinicopathologic and immunohistochemical study of 84
cases. Am J Surg Pathol. 1995;19:859-872.
22. Coffin CM, Humphrey PA, Dehner LP. Extrapulmonary
inflammatory myofibroblastic tumor: a clinical and pathologic
survey. Semin Diagn Pathol. 1998;15:85-101.
23. Meis JM, Enzinger FM. Inflammatory fibrosarcoma of the
mesentery and retroperitoneum. A tumor closely simulating
inflammatory pseudotumor.Am J Surg Pathol. 1991;15:1146-1156.
24. Lee DH, Lee SH, Sung JK. Inflammatory Myofibroblastic Tumor
on Intercostal Nerve Presenting as Paraneoplastic Pemphigus
with Fatal Pulmonary Involvement. J Korean Med Sci. 2007;22:
735-739.
